Latest news with #SigmaHealthcare
News.com.au
4 days ago
- Business
- News.com.au
Stock Tips: One expert makes a Sigma call, Aussie Broadband connects with another
It's no easy gig analysing share prices and company performance but somebody's got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations. Toby Grimm – Baker Young Limited BUY Sigma Healthcare (ASX:SIG) Sigma's merger with Chemist Warehouse created Australia's dominant vertically integrated pharmacy group with a high growth outlook given our ageing population and wellness trends. Pinnacle Investment (ASX:PNI) Pinnacle should benefit significantly from the market's rally back to all-time highs with base and performance fees likely to exceed recently downgraded expectations. HOLD South32 (ASX:S32) The company's quarterly production update showed encouraging operational performance, and we note the Hermosa project in the US could be a tier one asset given supportive US critical mineral security policy. Woodside Energy Group (ASX:WDS) Alongside a relatively impressive quarterly output report, Woodside has confirmed key development projects are on track reducing risk and improving free cash flow available for distributions. SELL AMP (ASX:AMP) Recent share price appreciation underestimates continued competitive challenges and continuing investment needs. Combined with sub-optimal bank operations we see risks of setbacks and would be exiting. Helia Group (ASX:HLI) The loss of Commonwealth Bank and potentially ING mortgage insurance contracts (combined worth more than half the business' premiums in 2024) underscores a lack of competitive advantage and growth. Tony Paterno – Ord Minnett BUY Aussie Broadband (ASX:ABB) Remains well placed to grow market share as consumers trend to higher speed tiers and the NBN's fibre upgrade program rolls out. ARB Corporation (ASX:ARB) Australian new vehicles sales increased by 2.4% in Jun-25. ARB's key vehicle sales increased 15.0% in June, with the SUV and LCV market both lifting. HOLD Bapcor (ASX:BAP) After the recent strategy day, the company's key messages are on business simplification, continuing cost initiatives and improving retail operations. It expects operational improvements following headcount reductions and warehouse consolidation. Brickworks (ASX:BKW) Demand for BKW's Industrial property developments remain solid, with further growth in rental income expected. In Australia, recent rate cuts are expected to translate into improved housing activity late in 2025. SELL Evolution Mining (ASX:EVN) EVN delivered a slightly softer quarter result (higher capex), whilst the outlook showed higher costs. Trading expensive at these levels. Lynas (ASX:LYC) We believe the optimistic LYC share price rise since the MP Materials & DoD deal is misplaced. We don't believe they will benefit and the US has gone all-in on its domestic producer.
Herald Sun
07-06-2025
- Business
- Herald Sun
Stock Tips: Never mind the alpha, what's the Sigma play this week?
It's no easy gig analysing share prices and company performance but somebody's got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations. Sean Conlan – Leyland Private Asset Management BUY Sigma Healthcare (ASX:SIG) We believe SIG will grow into its current PE multiple by refurbishing existing Chemist Warehouse stores, opening 20 new stores per annum across Australia and by exporting the brand offshore. Judo Capital Holdings (ASX:JDO) Improved funding costs give us more comfort on the near-term margin outlook. With forecast a~34% earnings CAGR over the next three years, and trading at only 12x FY26 P/E we think the valuation is attractive. HOLD Treasury Wine Estates (ASX:TWE) TWE has trimmed guidance for FY25 earnings growth, citing lower-than-expected wine sales in the US where economic uncertainty is hurting consumer demand. Austal (ASX:ASB) We remain positive on the long-term outlook for ASB, considering the macro tailwinds and attractive growth profile, however, we are conscious of its current valuation. SELL Bank of Queensland (ASX:BOQ) While BOQ's simplification strategy and pivot towards business is bearing fruit, we think it will continue to struggle to make returns above the cost of capital over the medium term. Lovisa Holdings (ASX:LOV) We are concerned about the quality of stores recently opened and think that higher-than-normal rates of discounting may be driving strong LFL sales. Chris Watt – Bell Potter Securities BUY CAR Group (CAR) Resilient RV sales, solid international operations and strong earnings momentum support continued growth. The company continues to benefit from a scalable global expansion strategy that allows it to replicate its model across international markets. Treasury Wine Estates (ASX:TWE) While the US premium wine market is weak, core luxury brands remain strong. DAOU Vineyards synergies and broader international opportunities provide upside despite recent downgrades. HOLD Technology One (ASX:TNE) A strong first-half result confirms the business is executing well, with growing recurring revenue and cash flow. However, recent share price gains limit short-term upside. James Hardie (ASX:JHX) Strategy execution in US new construction is on track, particularly in the southern states. That said, macro softness and affordability challenges persist. SELL IDP Education (ASX:IEL) Deteriorating student volumes and shifting global immigration policy have led to significant earnings downgrades. Visibility remains poor, and risks are elevated. Cettire (ASX:CTT) Weak margins, US tariff headwinds, and a soft cash position point to a challenging outlook. The path to profitability appears longer and riskier. The views, information, or opinions expressed in the interviews in this article are solely those of the interviewee and do not represent the views of Stockhead. Stockhead does not provide, endorse or otherwise assume responsibility for any financial advice contained in this article. Originally published as Stock Tips: Never mind the alpha, what's the Sigma play this week?
News.com.au
07-06-2025
- Business
- News.com.au
Stock Tips: Never mind the alpha, what's the Sigma play this week?
It's no easy gig analysing share prices and company performance but somebody's got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations. Sean Conlan – Leyland Private Asset Management BUY Sigma Healthcare (ASX:SIG) We believe SIG will grow into its current PE multiple by refurbishing existing Chemist Warehouse stores, opening 20 new stores per annum across Australia and by exporting the brand offshore. Judo Capital Holdings (ASX:JDO) Improved funding costs give us more comfort on the near-term margin outlook. With forecast a~34% earnings CAGR over the next three years, and trading at only 12x FY26 P/E we think the valuation is attractive. HOLD Treasury Wine Estates (ASX:TWE) TWE has trimmed guidance for FY25 earnings growth, citing lower-than-expected wine sales in the US where economic uncertainty is hurting consumer demand. Austal (ASX:ASB) We remain positive on the long-term outlook for ASB, considering the macro tailwinds and attractive growth profile, however, we are conscious of its current valuation. SELL Bank of Queensland (ASX:BOQ) While BOQ's simplification strategy and pivot towards business is bearing fruit, we think it will continue to struggle to make returns above the cost of capital over the medium term. Lovisa Holdings (ASX:LOV) We are concerned about the quality of stores recently opened and think that higher-than-normal rates of discounting may be driving strong LFL sales. Chris Watt – Bell Potter Securities BUY CAR Group (CAR) Resilient RV sales, solid international operations and strong earnings momentum support continued growth. The company continues to benefit from a scalable global expansion strategy that allows it to replicate its model across international markets. Treasury Wine Estates (ASX:TWE) While the US premium wine market is weak, core luxury brands remain strong. DAOU Vineyards synergies and broader international opportunities provide upside despite recent downgrades. HOLD Technology One (ASX:TNE) A strong first-half result confirms the business is executing well, with growing recurring revenue and cash flow. However, recent share price gains limit short-term upside. James Hardie (ASX:JHX) Strategy execution in US new construction is on track, particularly in the southern states. That said, macro softness and affordability challenges persist. SELL IDP Education (ASX:IEL) Deteriorating student volumes and shifting global immigration policy have led to significant earnings downgrades. Visibility remains poor, and risks are elevated. Cettire (ASX:CTT) Weak margins, US tariff headwinds, and a soft cash position point to a challenging outlook. The path to profitability appears longer and riskier.
AU Financial Review
30-05-2025
- Business
- AU Financial Review
Chemist Warehouse insiders dump shares worth $4.7b in mass exit
One franchisee has sold $650 million worth of Chemist Warehouse shares, another a stake valued at $380 million. Ever since the pharmacy giant's debut on the ASX through a merger with wholesaler Sigma Healthcare, its biggest shareholders have been making a mint offloading stock. In all, some 37 per cent of the $13.8 billion in shares that aren't restricted from sale have changed hands since the February backdoor listing, which created one of the largest companies on the ASX and transformed Chemist Warehouse's founders into some of the wealthiest people in the country.
AU Financial Review
15-05-2025
- Business
- AU Financial Review
Chemist Warehouse scion cashes out $380m
Damien Gance, the son of Chemist Warehouse co-founder Sam Gance, has sold a $380 million stake in Sigma Healthcare, the ASX-listed company that houses the pharmaceutical and retail giant created by his father. Gance, who is a Sigma director, has sold $800 million worth of stock in the company since February when Chemist Warehouse made its sharemarket debut via a $34 billion backdoor listing.
